NO175898C - Analogifremgangsmåte for fremstilling av terapeutisk virksomme 3-sykloalkylpropanamider og nye mellomprodukter for anvendelse ved fremgangsmåten - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk virksomme 3-sykloalkylpropanamider og nye mellomprodukter for anvendelse ved fremgangsmåten

Info

Publication number
NO175898C
NO175898C NO914232A NO914232A NO175898C NO 175898 C NO175898 C NO 175898C NO 914232 A NO914232 A NO 914232A NO 914232 A NO914232 A NO 914232A NO 175898 C NO175898 C NO 175898C
Authority
NO
Norway
Prior art keywords
carbon atoms
cycloalkylpropanamides
preparation
therapeutically effective
hal
Prior art date
Application number
NO914232A
Other languages
English (en)
Norwegian (no)
Other versions
NO914232D0 (no
NO175898B (no
NO914232L (no
Inventor
Philip Thomas Hambleton
Charles John Robert Hedgecock
David Paul Kay
Elizabeth Anne Kuo
Wilfred Roger Tully
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909023535A external-priority patent/GB9023535D0/en
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of NO914232D0 publication Critical patent/NO914232D0/no
Publication of NO914232L publication Critical patent/NO914232L/no
Publication of NO175898B publication Critical patent/NO175898B/no
Publication of NO175898C publication Critical patent/NO175898C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/27—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups, amino groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO914232A 1990-10-30 1991-10-29 Analogifremgangsmåte for fremstilling av terapeutisk virksomme 3-sykloalkylpropanamider og nye mellomprodukter for anvendelse ved fremgangsmåten NO175898C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909023535A GB9023535D0 (en) 1990-10-30 1990-10-30 Chemical compounds
GB919105516A GB9105516D0 (en) 1990-10-30 1991-03-15 Chemical compounds

Publications (4)

Publication Number Publication Date
NO914232D0 NO914232D0 (no) 1991-10-29
NO914232L NO914232L (no) 1992-05-04
NO175898B NO175898B (no) 1994-09-19
NO175898C true NO175898C (no) 1994-12-28

Family

ID=26297867

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914232A NO175898C (no) 1990-10-30 1991-10-29 Analogifremgangsmåte for fremstilling av terapeutisk virksomme 3-sykloalkylpropanamider og nye mellomprodukter for anvendelse ved fremgangsmåten

Country Status (25)

Country Link
US (2) US5240960B1 (de)
EP (1) EP0484223B1 (de)
JP (1) JP2594855B2 (de)
CN (1) CN1030075C (de)
AT (1) ATE119518T1 (de)
AU (1) AU641290B2 (de)
BG (1) BG61924B2 (de)
BR (1) BR9104711A (de)
CA (1) CA2054473C (de)
CZ (1) CZ282036B6 (de)
DE (1) DE69107959T2 (de)
DK (1) DK0484223T3 (de)
ES (1) ES2069854T3 (de)
FI (2) FI110511B (de)
GE (1) GEP19981035B (de)
GR (1) GR3015335T3 (de)
HR (1) HRP920979B1 (de)
HU (2) HU215051B (de)
IE (1) IE69330B1 (de)
IL (1) IL99811A (de)
NO (1) NO175898C (de)
NZ (1) NZ240403A (de)
PT (1) PT99381B (de)
SI (1) SI9111731B (de)
SK (1) SK281720B6 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf History of 3-cycloalkyl-prop-2-anamide
ATE128353T1 (de) * 1991-10-23 1995-10-15 Hoechst Ag N-phenyl-2-cyano-3-hydroxycrotonsäureamidderiva e und deren verwendung als arzneimittel mit immunmodulatorischer eigenschaft.
GB9200275D0 (en) * 1992-01-08 1992-02-26 Roussel Lab Ltd Chemical compounds
GB9300083D0 (en) * 1993-01-05 1993-03-03 Roussel Lab Ltd Chemical compounds
TW314467B (de) * 1993-03-31 1997-09-01 Hoechst Ag
GB9313365D0 (en) * 1993-06-29 1993-08-11 Roussel Lab Ltd Chemical compounds
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease
FR2727628B1 (fr) * 1994-12-02 1997-01-10 Roussel Uclaf Application des derives de 3-cycloalkyl-propanamide a titre de medicaments analgesiques
GB9520092D0 (en) * 1995-10-02 1995-12-06 Hoechst Roussel Ltd Chemical compounds
DE19539638A1 (de) * 1995-10-25 1997-04-30 Hoechst Ag Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
DE19547648A1 (de) 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
US6355678B1 (en) * 1998-06-29 2002-03-12 Parker Hughes Institute Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
AU731777B2 (en) 1998-11-30 2001-04-05 Nihon Nohyaku Co., Ltd. Aniline derivative and process for producing the same
US6566395B1 (en) * 1999-05-25 2003-05-20 Biomedicines, Inc. Methods of treating proliferative disorders
MX2016006678A (es) 2013-11-22 2016-09-13 Genzyme Corp Nuevos metodos para tratar enfermedades neurodegenerativas.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR831461A (fr) * 1937-01-09 1938-09-05 Ste Ind Chim Bale Nouveaux produits de condensation
US3116312A (en) * 1960-03-31 1963-12-31 American Cyanamid Co Substituted-2-cyanoacetanilides
NL6911567A (de) * 1968-08-08 1970-02-10
DE2307156A1 (de) * 1973-02-14 1974-08-22 Henkel & Cie Gmbh N,n-disubstituierte alpha-cyanacrylsaeureamide und deren herstellung
DE2555789A1 (de) * 1975-12-11 1977-07-07 Hoechst Ag Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4393217A (en) * 1981-01-12 1983-07-12 American Cyanamid Company Substituted phenyl-5-aminopyrazoles
US4946867A (en) * 1987-09-07 1990-08-07 Sumitomo Chemical Company, Limited Cyanoacetamide derivative, and plant disease protectant comprising the same as an active ingredient
US4888357A (en) * 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles
US5034410A (en) * 1989-10-11 1991-07-23 Syntex (U.S.A.) Inc. Anthelmintically active benzenepropanamide derivatives
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them

Also Published As

Publication number Publication date
BG61924B2 (bg) 1998-09-30
CS327391A3 (en) 1992-05-13
HU913394D0 (en) 1992-01-28
ATE119518T1 (de) 1995-03-15
CZ282036B6 (cs) 1997-04-16
CN1030075C (zh) 1995-10-18
FI915091A (fi) 1992-05-01
AU641290B2 (en) 1993-09-16
SK281720B6 (sk) 2001-07-10
HUT59661A (en) 1992-06-29
SI9111731B (en) 2001-02-28
IE69330B1 (en) 1996-09-04
HU215051B (hu) 1998-12-28
IE913768A1 (en) 1992-05-22
NO914232D0 (no) 1991-10-29
CN1064482A (zh) 1992-09-16
IL99811A0 (en) 1992-08-18
AU8686991A (en) 1992-05-07
FI110511B (fi) 2003-02-14
DE69107959T2 (de) 1995-11-16
HRP920979B1 (en) 2000-06-30
US5240960B1 (en) 1995-05-02
FI119986B (fi) 2009-05-29
JPH04288048A (ja) 1992-10-13
EP0484223A2 (de) 1992-05-06
ES2069854T3 (es) 1995-05-16
CA2054473C (fr) 2003-07-29
FI20021681A (fi) 2002-09-20
DE69107959D1 (de) 1995-04-13
US5384423A (en) 1995-01-24
HU211614A9 (en) 1995-12-28
PT99381A (pt) 1992-09-30
FI915091A0 (fi) 1991-10-29
EP0484223B1 (de) 1995-03-08
NO175898B (no) 1994-09-19
BR9104711A (pt) 1992-06-16
IL99811A (en) 1996-03-31
PT99381B (pt) 1999-04-30
US5240960A (en) 1993-08-31
NO914232L (no) 1992-05-04
CA2054473A1 (fr) 1992-05-01
JP2594855B2 (ja) 1997-03-26
SI9111731A (en) 1997-12-31
NZ240403A (en) 1994-10-26
HRP920979A2 (en) 1997-12-31
EP0484223A3 (en) 1993-04-07
GR3015335T3 (en) 1995-06-30
DK0484223T3 (da) 1995-06-19
GEP19981035B (en) 1998-03-26

Similar Documents

Publication Publication Date Title
NO175898C (no) Analogifremgangsmåte for fremstilling av terapeutisk virksomme 3-sykloalkylpropanamider og nye mellomprodukter for anvendelse ved fremgangsmåten
SE8201854L (sv) N-substituerade amino-aminosyror
SE8800638L (sv) Antihypercholesterolemic tetrazole compounds
DE69311118D1 (de) Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung
ATE185143T1 (de) Glatten-muskelzellen-proliferation-inhibitoren
ES8301220A1 (es) Procedimiento para la preparacion de derivados de imidazol
ATE86486T1 (de) Verwendung von aromatischen carbonsaeureamiden.
TW215947B (de)
MY104955A (en) Pyrroloquinoline and pyrrolophemothiazine carboxamides and related compounds.
DE69902766D1 (de) N-aryloxyethylaminderivate zur behandlung der depression
NO883522D0 (no) Fremgangsmaate for fremstilling av terapeutisk virksomme imidazo-benzodiazepiner.
DE3587653D1 (de) Sparsomycinderivate.
JO1635B1 (en) New compounds to shrink the people and a process to prepare them
FI833971A (fi) Nya semikarbazider, deras framstaellning och anvaendning

Legal Events

Date Code Title Description
MK1K Patent expired